Image: Noom

Noom, the digital weight management platform known for its behavior change approach, has announced its expansion into Hormone Replacement Therapy (HRT) to support women experiencing menopause. The new offering, Noom + HRTRx, integrates hormone therapy with the company’s established weight management and behavior change program.

Since its founding, Noom has welcomed over 8 million women aged 40 to 60 into its program, with many reporting how menopause-related symptoms create additional challenges in their weight loss journey. The company notes that despite progress in women’s health, only 30% of women seeking menopause treatment receive the care they need.

“In recent years, we have witnessed a growing acknowledgment of women’s unique health challenges. However, acknowledgement alone is insufficient,” said Dr. Karen Mann, Medical Director of Noom. “We must proactively address these challenges with targeted health solutions that support women through these key life stages. Noom’s holistic approach ensures that women thrive in every aspect of their lives.”

The new program addresses the over 30 unique symptoms of menopause by combining FDA-approved and compounded bioidentical hormones with Noom’s core features: personalized content, food tracking, resistance-training workouts, and coaching support. Pricing begins at $69 to start, then $89/month for cream options, and $99 to start, then $149/month for patch options.

“The menopause care gap is real,” said Geoff Cook, Chief Executive Officer of Noom. “A generation of clinicians have underprescribed HRT, owing to misleading conclusions related to a now outdated 2002 study. Millions of women and their doctors abandoned HRT treatment virtually overnight. Since then, a strong case has been made that HRT is a healthy choice for most women. Hormonal changes during menopause can have life-altering effects, impacting longevity, vitality, metabolism, and overall well-being.”

This expansion follows Noom’s recent growth in medically-assisted weight loss, including GLP-1Rx and pill-based medications, which reportedly grew to a $100 million revenue run-rate business within four months. The new HRT program will initially be available to new Noom Healthy Weight subscribers who meet eligibility criteria, with plans to offer it as an upgrade to existing customers later this year.

Show CommentsClose Comments

Leave a comment